An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib plus radiation for newly-diagnosed glioblastoma (GBM) patients. Conference

Chakravarti, A, Seiferheld, W, Robins, HI et al. (2004). An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib plus radiation for newly-diagnosed glioblastoma (GBM) patients. . JOURNAL OF CLINICAL ONCOLOGY, 22(14), 124S-124S.

International Collaboration

cited authors

  • Chakravarti, A; Seiferheld, W; Robins, HI; Guha, A; Brachman, D; Curran, W; Choucair, A; Mehta, M

sustainable development goals

authors

date/time interval

  • June 5, 2004 -

publication date

  • July 15, 2004

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • New Orleans, LA

Conference

  • 40th Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 124S

end page

  • 124S

volume

  • 22

issue

  • 14